Collplant Biotechnologies Ltd (CLGN) Stock Forecast Oct. 13, 2026
Analysis updated on Oct. 13, 2026 (UTC) · Total · absolute moveSwitch to Alpha · Nasdaq
Collplant Biotechnologies Ltd (CLGN) stock forecast summary
On Oct. 13, 2026, CLGN is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 5379 stocks scored that day.
Collplant Biotechnologies Ltd is a small-cap company with a market capitalization of $5M. It ranks number 22 by market capitalization among the 24 Orthopedic, Prosthetic & Surgical Appliances & Supplies issuers in our coverage with a current forecast.
A per-ticker accuracy statistic for CLGN is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +4.5%, buy ≥ +3.4%, sell < +2.1%, strong sell < +0.9% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, CLGN included.
Follow CLGN freeCLGN price chart and AI forecast
How CLGN ranks among 5379 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Collplant Biotechnologies Ltd (CLGN) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Orthopedic, Prosthetic & Surgical Appliances & Supplies peers listed below that report each metric.
Reported net income does not reconcile with earnings per share and the share count, so net-income-based ratios are withheld.
Valuation & Market
| Metric | CLGN | Rank |
|---|---|---|
| Market Cap | $5M | 22/24 |
| P/B Ratio | 0.85x | 17/19 |
| EPS | $-2.39 | – |
| Book Value/Share | $4.75 | – |
Profitability & Margins
| Metric | CLGN | Rank |
|---|---|---|
| Gross Margin | 14.8% | 18/20 |
| Operating Margin | -995.6% | 19/21 |
| EBT Margin | -995.6% | 19/21 |
Financial Health
| Metric | CLGN | Rank |
|---|---|---|
| Current Ratio | 2.53x | 13/24 |
| Quick Ratio | 2.31x | 8/21 |
| D/E Ratio | 0.77x | 11/23 |
| Financial Leverage | 1.77x | 11/23 |
| Working Capital | $4M | 18/22 |
Cash Flow
| Metric | CLGN | Rank |
|---|---|---|
| Operating Cash Flow | -$24M | 20/22 |
Operational Efficiency
| Metric | CLGN | Rank |
|---|---|---|
| Inventory Turnover | 4.3x | 6/21 |
| Days Inventory | 85 days | 16/21 |
Income Statement
| Metric | CLGN | Rank |
|---|---|---|
| Operating Income | -$28M | 19/22 |
| R&D Expense | $19M | 10/19 |
| Cost of Goods Sold | $2M | 16/20 |
Dividend & Shareholder Information
| Metric | CLGN | Rank |
|---|---|---|
| Shares Outstanding | 1M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $7M | 62.7% of assets |
| Cash & Short-term Investments | $6M | 52.0% of assets |
| Accounts Receivable | $0.00M | 0.0% of assets |
| Inventory | $570K | 5.3% of assets |
| Total Liabilities | $5M | 43.7% of assets |
CLGN quarterly financials and insider trading
Collplant Biotechnologies Ltd (CLGN) industry peers
Companies classified under the same SEC industry code as Collplant Biotechnologies Ltd (Orthopedic, Prosthetic & Surgical Appliances & Supplies): 27 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| CLGN Collplant Biotechnologies Ltd | ▶ | $5M |
| ISRG Intuitive Surgical Inc | ▼ | $149.10B |
| SNN Smith & Nephew Plc | ▼ | $24.45B |
| STE Steris Plc | ▼ | $21.23B |
| ZBH Zimmer Biomet Holdings, Inc. | ▼ | $17.56B |
| ALGN Align Technology Inc | ▶ | $10.20B |
| MSA Msa Safety Inc | ▼ | $7.01B |
| ESTA Establishment Labs Holdings Inc. | ▲ | $1.74B |
| CDRE Cadre Holdings, Inc. | ▲ | $1.12B |
| ENOV Enovis Corp | ▶ | $1.10B |
| AVR Anteris Technologies Global Corp. | ▼ | $629M |
| SMTI Sanara Medtech Inc. | ▼ | $323M |
| INGN Inogen Inc | ▶ | $168M |
| LAKE Lakeland Industries Inc | ▲ | $97M |
| NTRB Nutriband Inc. | ▲ | $71M |
| APT Alpha Pro Tech Ltd | ▲ | $59M |
| MYO Myomo, Inc. | ▲ | $51M |
| COCH Envoy Medical, Inc. | ▲ | $50M |
| MLSS Milestone Scientific Inc. | ▲ | $31M |
| LFWD Lifeward Ltd. | ▲ | $18M |
| UEEC United Health Products, Inc. | ▶ | $12M |
| RGNT Regentis Biomaterials Ltd. | ▶ | $8M |
| RBOT Vicarious Surgical Inc. | ▶ | $360K |
| FEED Envue Medical, Inc. | ▼ | $320K |
| BBLG Bone Biologics Corp | ▶ | N/A |
| CUPR Cuprina Holdings (Cayman) Ltd | ▼ | N/A |
| LGMK Logicmark, Inc. | ▶ | N/A |
Where CLGN sits on the market map
Collplant Biotechnologies Ltd (CLGN) stock news
Loading...
Collplant Biotechnologies Ltd (CLGN) stock forecast FAQ
What is the Collplant Biotechnologies Ltd (CLGN) stock forecast?
On Oct. 13, 2026, CLGN is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 5379 stocks scored that day.
How accurate are Collplant Biotechnologies Ltd stock predictions?
A per-ticker accuracy statistic for CLGN is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Collplant Biotechnologies Ltd forecasts updated?
Collplant Biotechnologies Ltd forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.
Which companies are Collplant Biotechnologies Ltd's industry peers?
27 issuers in our coverage, CLGN included, share the SEC industry code Orthopedic, Prosthetic & Surgical Appliances & Supplies. The largest are: Intuitive Surgical Inc (ISRG), Smith & Nephew Plc (SNN), Steris Plc (STE), Zimmer Biomet Holdings, Inc. (ZBH), Align Technology Inc (ALGN), Msa Safety Inc (MSA).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.